An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis

Juan P. Arab, Tejasav S. Sehrawat, Douglas A. Simonetto, Vikas K. Verma, Dechun Feng, Tom Tang, Kevin Dreyer, Xiaoqiang Yan, William L. Daley, Arun Sanyal, Naga Chalasani, Svetlana Radaeva, Liu Yang, Hugo Vargas, Mauricio Ibacache, Bin Gao, Gregory J. Gores, Harmeet Malhi, Patrick S. Kamath, Vijay H. Shah – 27 November 2019

Subscribe to